Effect of viruses and interferon on chick embryo otocyst cultures

A H Shikani1, W J Richtsmeier

  • 1Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland.

Insights

Viral infections in developing chick otocysts cause cell death and delayed differentiation. Interferon (IFN) partially protects against these effects without harming the otocyst, suggesting viruses, not IFN, cause congenital deafness.

Area of Science:

  • Developmental Biology
  • Virology
  • Oto-toxicology

Background:

  • Congenital deafness can be associated with viral infections during development.
  • The role of viral infections and the body's immune response, specifically interferon (IFN), in inner ear development is not fully understood.

Purpose of the Study:

  • To investigate the effects of vesicular stomatitis virus and rubella virus on chick embryo otocyst development in vitro.
  • To determine the protective role of interferon (IFN) against viral-induced damage in the developing otocyst.
  • To elucidate whether the virus or IFN is responsible for potential peripheral defects leading to congenital deafness.

Main Methods:

  • Chick embryo otocyst organ cultures were exposed to live viruses (vesicular stomatitis virus, rubella virus), interferon (IFN), or a combination.
  • Morphological and microscopic changes were assessed.
  • Time-lapse videophotography was employed to observe cellular dynamics.
  • Control untreated otocysts were used for comparison.

Main Results:

  • Virus exposure led to cell death, delayed differentiation, and reduced otocyst size.
  • Low-dose IFN pretreatment partially mitigated virus-induced damage.
  • IFN alone did not impede otocyst differentiation.
  • IFN demonstrated a partial protective effect against viral insult in vitro without apparent toxicity.

Conclusions:

  • The peripheral component of congenital deafness linked to viral infections is likely caused by the virus itself, not by the host's interferon response.
  • Interferon offers partial protection against viral damage to the developing otocyst in vitro.
  • Interferon does not appear to be toxic to the developing otocyst, suggesting a potential therapeutic window.

Related Concept Videos